Search

everythinglearnresearchcommunity

for

Search:↓

Patients with acanthosis nigricans often have insulin resistance and signs of increased male hormones, but treatment targeting these male hormones is generally ineffective.

More PDCD4 is linked to obesity, insulin problems, and cell death in ovaries for those with polycystic ovary syndrome.

Many young Italian women have hyperandrogenic disorders like PCOS, which are linked to age, body weight, and insulin resistance.

Women with severe types of PCOS are more likely to have metabolic syndrome, and belly fat is a key predictor of this risk.

The study suggests that being overweight or obese, not PCOS itself, is strongly linked to insulin resistance.

Girls with PCOS during adolescence have a higher risk of developing type 2 diabetes, and early treatment can help manage this risk.

Metformin helps manage diabetes, PCOS, and weight in kids but needs more research for long-term safety.

Insulin resistance is common in PCOS patients and linked to obesity and increased cardiovascular risk.

Changing the diagnosis criteria for PCOS might miss women at risk for related health issues.

Overweight women with PCOS have higher levels of certain hormones that could indicate a higher risk of heart and metabolic problems.

Women with PCOS have similar bone density to healthy women, but those who are obese have higher bone density at some body sites.

Lower vaspin levels in the blood may indicate a better response to fertility treatment in women with PCOS.

Women with PCOS have more insulin resistance and are more likely to have heart-related health issues, with insulin resistance being a bigger factor than β-cell problems.

High Lipid Accumulation Product levels are linked to more hirsutism in women with Polycystic Ovary Syndrome.

Managing metabolic syndrome needs both lifestyle changes and medical treatments.

Women with the NIH type of PCOS have more obesity and higher risk of diabetes and heart disease than those with other types of PCOS.

PCOS is common among Chinese women of reproductive age and linked to serious metabolic and reproductive issues, especially in obese women.

Metformin helps manage polycystic ovary syndrome by improving insulin resistance and ovulation, but more research is needed on its full effects.

High androgen levels in young women with PCOS are linked to higher blood pressure.

Vitamin D has potential benefits for cancer prevention, heart health, diabetes, obesity, muscle function, skin health, and immune function, but clinical results are mixed and more research is needed.

New treatments for male hypogonadism are effective and should be personalized.

Women with PCOS who have low SHBG are more likely to have low good cholesterol and metabolic syndrome.

Hirsutism is a strong sign of high male hormones and metabolic problems in women with PCOS, but acne and hair loss are not.

Adults with polycystic ovary syndrome are much more likely to have obstructive sleep apnea.

People with polycystic ovary syndrome have a higher chance of having chronic thyroiditis.

SHBG may be a useful early indicator and treatment target for PCOS.

Women with PCOS are more likely to have sleep apnea, mainly if they are obese.

Some skin conditions may indicate metabolic syndrome, which could help with early detection and management of related health issues.

High androgen levels in Chinese women with PCOS are linked to a higher risk of diabetes and obesity.

Spironolactone improved blood vessel function and cholesterol levels in non-obese women with PCOS.